Ladder Capital Corp to Report Second Quarter 2025 Results
NEW YORK–(BUSINESS WIRE)–Ladder Capital Corp (NYSE: LADR) (“we,” “Ladder,” or the “Company”) will release its second quarter 2025 results... Read more.
BWXT Announces $2.6 Billion in Contracts for Naval Nuclear Reactor Components
LYNCHBURG, Va.–(BUSINESS WIRE)–BWX Technologies, Inc. (NYSE: BWXT) announced today the award of U.S. Naval Nuclear Propulsion Program contracts totaling... Read more.
T-Mobile Takes Friday Night 5G Lights to a Whole. New. Level: More Winners, More Ways to Win and $4M in Total Prizes Up for Grabs
The Un-carrier’s nationwide competition to level the playing field for small towns returns with Patrick Mahomes and Rob Gronkowski rallying high schools to share... Read more.
June 2025 Monthly Release
NORTHBROOK, Ill.–(BUSINESS WIRE)–The Allstate Corporation (NYSE: ALL) today announced estimated catastrophe losses for the month of June of $619 million... Read more.
New Study Shows That Innovative Methodology Powered by Sensome Technology Successfully Monitors Cancer Progression
Paper Published in Science Advances Unveils Results of Multi-Year Collaboration between Sensome, École Polytechnique and French National Center for Scientific Research... Read more.
Raymond Karrenbauer Appointed Group Chief Information Officer at Hamilton
PEMBROKE, Bermuda–(BUSINESS WIRE)–#ingoodcompany–Hamilton Insurance Group, Ltd. (NYSE: HG) (“Hamilton” or the “Company”) today announced... Read more.
Dualboot Partners Announces Availability of 3PO in the New AWS Marketplace AI Agents and Tools Category
CHARLOTTE, N.C.–(BUSINESS WIRE)–#AWSMarketplace–Dualboot Partners, a leading provider of powerful AI-powered digital modernization solutions, today... Read more.
YETI Holdings, Inc. Announces Reporting Date for Second Quarter Fiscal 2025 Financial Results
AUSTIN, Texas–(BUSINESS WIRE)–YETI Holdings, Inc. (“YETI”) (NYSE: YETI) today announced that it plans to report its second quarter fiscal year 2025... Read more.
ENHERTU® Plus Pertuzumab Granted Breakthrough Therapy Designation in the U.S. as First-Line Therapy for Patients with HER2 Positive Metastatic Breast Cancer
Ninth Breakthrough Therapy Designation for Daiichi Sankyo and AstraZeneca’s ENHERTU with the latest based on DESTINY-Breast09 phase 3 trial results Thirteenth... Read more.
QT Imaging Launches QTviewer 2.8 to Enhance Clinical Efficiency and Diagnostic Accuracy
NOVATO, Calif.–(BUSINESS WIRE)–QT Imaging Holdings, Inc. (OTCQB: QTIH), a medical device company engaged in research, development, and commercialization... Read more.